Baker Bros. Advisors LP Matinas Bio Pharma Holdings, Inc. Transaction History

Baker Bros. Advisors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$0.67 - $0.96 $1.4 Million - $2.01 Million	-2,096,375 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$0.52 - $0.92 $862,079 - $1.53 Million	-1,657,846 Reduced 44.16%	2,096,375 $1.62 Million
Q1 2020 May 15, 2020	BUY	$0.6 - $2.31 $673,123 - $2.59 Million	1,121,873 Added 42.62%	3,754,221 $2.25 Million
Q4 2019 Feb 14, 2020	BUY	$0.63 - $2.27 $407,851 - $1.47 Million	647,383 Added 32.61%	2,632,348 $5.98 Million
Q3 2019 Nov 14, 2019	BUY	$0.59 - $0.9 $1.17 Million - $1.79 Million	1,984,965 New	1,984,965 $1.25 Million

3.52M

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $130M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Baker Bros. Advisors LP with notifications on news.